Related references
Note: Only part of the references are listed.A novel spontaneous mutation of Irs1 in mice results in hyperinsulinemia, reduced growth, low bone mass and impaired adipogenesis
Victoria E. DeMambro et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing
Jared C. Roach et al.
SCIENCE (2010)
SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival
Laura Tonnetti et al.
CANCER RESEARCH (2008)
DNA repair in murine embryonic stem cells and differentiated cells
Elisia D. Tichy et al.
EXPERIMENTAL CELL RESEARCH (2008)
Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice
Colin Selman et al.
FASEB JOURNAL (2008)
Genomic copy number and expression variation within the C57BL/6J inbred mouse strain
Dawn E. Watkins-Chow et al.
GENOME RESEARCH (2008)
Gene targeting in embryonic stem cells scores a knockout in Stockholm
Tak Wah Mak
CELL (2007)
Deficiency of plasminogen activator inhibitor-2 impairs nutritionally induced murine adipose tissue development
H. R. Lijnen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Murine models of vascular thrombosis (Eitzman series)
Randal J. Westrick et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
SerpinB2 is an inducible host factor involved in enhancing HIV-1 transcription and replication
Grant A. Darnell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
NF-κB translocation prevents host cell death after low-dose challenge by Legionella pneumophila
Vicki P. Losick et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Tissue-specific roles of IRS proteins in insulin signaling and glucose transport
ACP Thirone et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
The undecided serpin - The ins and outs of plasminogen activator inhibitor type 2
RL Medcalf et al.
FEBS JOURNAL (2005)
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
CM Taniguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: Lessons from Fierce mice
RA Kumar et al.
GENESIS (2004)
Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice
RN Kulkarni et al.
DIABETES (2003)
Direct estimates of human per nucleotide mutation rates at 20 loci causing Mendelian diseases
AS Kondrashov
HUMAN MUTATION (2003)
Embryonic stem cells and somatic cells differ in mutation frequency and type
RB Cervantes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice
PC Scacheri et al.
GENESIS (2001)
Myf-5 revisited:: Loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice
A Kaul et al.
CELL (2000)
Restored insulin-sensitivity in IRS-1-deficient mice treated by adenovirus-mediated gene therapy
K Ueki et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Genetic modifiers of the insulin resistance phenotype in mice
Y Kido et al.
DIABETES (2000)
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
Y Kido et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
